CliffBio
small molecule

FEMLYV

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Loss of exclusivityJune 2041latest FDA-listed patent expiry
CompanyMILLICENT MANUFACTURING PR LLC

Drug detail

Brand nameFEMLYV
Active ingredientETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Strength0.02MG;1MG
Dosage formTABLET, ORALLY DISINTEGRATING
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2024
Marketing statusRX

Listed patents

PatentExpiresType
12178824June 2041product

Regulatory exclusivity

CodeExpires
NPJuly 2027

More from MILLICENT MANUFACTURING PR LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.